48,460
edits
Difference between revisions of "Secretory carcinoma of the salivary gland"
Jump to navigation
Jump to search
Secretory carcinoma of the salivary gland (view source)
Revision as of 20:53, 2 November 2021
, 20:53, 2 November 2021→Sign out
(fix) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 111: | Line 111: | ||
Note: | Note: | ||
*The translocation seen in [[secretory breast carcinoma]], [[congenital-infantile fibrosarcoma]] and [[mesoblastic nephroma]]. | *The translocation seen in [[secretory breast carcinoma]], [[congenital-infantile fibrosarcoma]] and [[mesoblastic nephroma]]. | ||
==Sign out== | |||
<pre> | |||
Right Parotid Lesion, Core Biopsy: | |||
- SECRETORY CARCINOMA of the salivary gland, see comment. | |||
Comment: | |||
Secretory carcinoma of the salivary gland was previously known as "mammary analogue secretory carcinoma" (MASC). | |||
The tumour stains as follows: | |||
POSITIVE: CK7 (strong, diffuse), mammaglobin (strong, diffuse), S100 (moderate, patchy), mucin (focal). | |||
NEGATIVE: p63. | |||
NTRK testing was ordered; the results will be reported in an addendum. | |||
</pre> | |||
===Micro=== | |||
The sections show a cohesive tumor with moderate amphophilic cytoplasm and vacuolation. The vacuolation is focally prominent. Nucleoli are inconspicuous. Poorly formed glands are present. Keratinization is absent. | |||
==See also== | ==See also== | ||